July 22 (Reuters) - SeaStar Medical Holding Corp ICU.O:
SEASTAR MEDICAL REPORTS POSITIVE RESULTS FOR QUELIMMUNE THERAPY IN PEDIATRIC ACUTE KIDNEY INJURY (AKI) FROM THE FIRST 20 SAVE SURVEILLANCE REGISTRY PATIENTS
SEASTAR MEDICAL: SAVE SURVEILLANCE REGISTRY NEW DATA ON TRACK TO VALIDATE/POTENTIALLY EXCEED 50% REDUCTION IN LOSS OF LIFE VERSUS HISTORICAL DATA
Source text: ID:nGNX5MD78Q
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))